Demonstration_NN
of_IN
a_DT
1,25-dihydroxyvitamin_NN
D3-responsive_JJ
protein_NN
in_IN
human_JJ
lymphocytes_NNS
:_:
immunologic_JJ
crossreactivity_NN
and_CC
inverse_JJ
regulation_NN
with_IN
the_DT
vitamin_NN
D_NN
receptor_NN
._.

Using_VBG
Western_NN
blot_NN
analysis_NN
with_IN
a_DT
monoclonal_JJ
antibody_NN
recognizing_VBG
a_DT
17-amino_NN
acid_NN
epitope_NN
of_IN
the_DT
1,25-dihydroxyvitamin_NN
D3_NN
-LCB-_-LRB-
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
-RCB-_-RRB-
receptor_NN
,_,
we_PRP
have_VBP
detected_VBN
two_CD
crossreacting_VBG
proteins_NNS
in_IN
activated_VBN
normal_JJ
human_JJ
lymphocytes_NNS
._.

The_DT
smaller_JJR
of_IN
the_DT
two_CD
proteins_NNS
-LRB-_-LRB-
50_CD
kDa_NN
-RRB-_-RRB-
was_VBD
indistinguishable_JJ
from_IN
the_DT
classical_JJ
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
and_CC
,_,
similar_JJ
to_TO
the_DT
classical_JJ
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
receptor_NN
,_,
was_VBD
upregulated_VBN
in_IN
a_DT
dose-dependent_JJ
fashion_NN
by_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
._.

The_DT
larger_JJR
crossreacting_VBG
protein_NN
exhibited_VBD
an_DT
electrophoretic_JJ
mobility_NN
of_IN
80_CD
kDa_NN
,_,
was_VBD
localized_JJ
in_IN
the_DT
cell_NN
cytosol_NN
,_,
and_CC
appeared_VBD
to_TO
be_VB
specific_JJ
for_IN
activated_VBN
lymphocytes_NNS
since_IN
it_PRP
was_VBD
not_RB
detected_VBN
in_IN
several_JJ
other_JJ
human_JJ
cells_NNS
including_VBG
monocytes_NNS
._.

More_RBR
strikingly_RB
,_,
the_DT
80-kDa_JJ
protein_NN
was_VBD
downregulated_VBN
in_IN
a_DT
dose-dependent_JJ
fashion_NN
by_IN
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
;_:
this_DT
effect_NN
was_VBD
independent_JJ
of_IN
the_DT
mode_NN
of_IN
lymphocyte_NN
activation_NN
and_CC
specific_JJ
for_IN
the_DT
1,25_CD
-LRB-_-LRB-
OH_NN
-RRB-_-RRB-
2D3_NN
metabolite_NN
of_IN
vitamin_NN
D3_NN
._.

However_RB
,_,
two_CD
potent_JJ
immunosuppressive_JJ
agents_NNS
,_,
glucocorticoids_NNS
and_CC
cyclosporin_NN
A_NN
,_,
also_RB
inhibited_VBD
the_DT
80-kDa_JJ
protein_NN
._.

